首页> 外文期刊>BMJ Open >A cross-sectional assessment of the prevalence of multiple chronic conditions and medication use in a sample of community-dwelling adults with fibromyalgia in Olmsted County, Minnesota
【24h】

A cross-sectional assessment of the prevalence of multiple chronic conditions and medication use in a sample of community-dwelling adults with fibromyalgia in Olmsted County, Minnesota

机译:在明尼苏达州奥姆斯特德县的社区居民中患有纤维肌痛的成年人中,多种慢性病患病率和用药情况的横断面评估

获取原文
           

摘要

Objectives The objective of this study was to evaluate the problem of multiple chronic conditions and polypharmacy in patients with fibromyalgia. Design Retrospective medical record review. Setting Olmsted County, Minnesota. Participants 1111 adults with fibromyalgia. Primary and secondary outcome measures Number and type of chronic medical and psychiatric conditions, medication use. Results Medical record review demonstrated that greater than 50% of the sample had seven or more chronic conditions. Chronic joint pain/degenerative arthritis was the most frequent comorbidity (88.7%), followed by depression (75.1%), migraines/chronic headaches (62.4%) and anxiety (56.5%). Approximately, 40% of patients were taking three or more medications for symptoms of fibromyalgia. Sleep aids were the most commonly prescribed medications in our sample (33.3%) followed by selective serotonin reuptake inhibitors (28.7%), opioids (22.4%) and serotonin norepinephrine reuptake inhibitors (21.0%). Conclusions The results of our study highlight the problem of multiple chronic conditions and high prevalence of polypharmacy in fibromyalgia. Clinicians who care for patients with fibromyalgia should take into consideration the presence of multiple chronic conditions when recommending medications.
机译:目的这项研究的目的是评估纤维肌痛患者的多种慢性疾病和多药治疗问题。设计回顾性病历审查。设置明尼苏达州的奥尔姆斯特德县。参与者1111名患有纤维肌痛的成人。主要和次要结局指标慢性医学和精神疾病的数量和类型,药物的使用。结果病历审查表明,超过50%的样本患有7种或更多种慢性病。慢性关节痛/变性关节炎是最常见的合并症(88.7%),其次是抑郁症(75.1%),偏头痛/慢性头痛(62.4%)和焦虑症(56.5%)。大约有40%的患者因纤维肌痛症状正在服用三种或更多种药物。睡眠辅助剂是我们样本中最常用的处方药物(33.3%),其次是选择性的5-羟色胺再摄取抑制剂(28.7%),阿片类药物(22.4%)和5-羟色胺去甲肾上腺素再摄取抑制剂(21.0%)。结论我们的研究结果突出了纤维肌痛的多种慢性病和多药高发的问题。护理纤维肌痛患者的临床医生在推荐药物治疗时应考虑多种慢性病的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号